Pancreatic Cancer Research

ResearcherThe Ohio State University Wexner Medical CenterNo recent work listed

John F. P. Bridges

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3082-5535; OpenAlex author ID A5072733056. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
8
Papers, trials and grants by year

2020: 3 papers · 2021: 1 paper

Papers 4

  1. Patient experience and quality of life during neoadjuvant therapy for pancreatic cancer: a systematic review and study protocol. Last author DOI 10.1007/s00520-020-05813-2↗
  2. Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials. Co-author DOI 10.3390/jcm9041129↗
  3. Neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma: The need for patient-centered research. Last author DOI 10.3748/wjg.v26.i4.375↗
  4. Disparities in the Use of Neoadjuvant Therapy for Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.6004/jnccn.2019.7380↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Allan Tsung · 4 shared papers, 2020–2021 · strength 0.51
  2. Jordan M. Cloyd · 4 shared papers, 2020–2021 · strength 0.51
  3. Heena P. Santry · 3 shared papers, 2020–2021 · strength 0.37
  4. Timothy Michael Pawlik · 2 shared papers, 2020 · strength 0.23
  5. Mary E. Dillhoff · 2 shared papers, 2020 · strength 0.23
  6. Aslam M. Ejaz · 2 shared papers, 2020 · strength 0.23
  7. Terence Marques Williams · 1 shared paper, 2020 · strength 0.11
  8. Laith I. Abushahin · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.